Subject: Smallcap Discoveries: IBEX Technologies (IBT-TSX.V) Interview with CEO Paul Baehr

Smallcap Discoveries:
IBEX Technologies (IBT-TSX.V) Interview with CEO Paul Baehr
On February 11th, we had an interview with CEO Paul Baehr of IBEX Technologies and below is a short summary on the company and our video interview.

ABOUT IBEX

IBEX manufactures and markets proteins for biomedical use through its wholly-owned subsidiary IBEX Pharmaceuticals Inc. (Montréal, QC). IBEX Pharmaceuticals also manufactures and markets a series of arthritis assays, which are widely used in osteoarthritis research.

Video Interview:
After our interviews, we host a session with the live participants to provide our thoughts on the Company as well as commentary on companies from both the Select Portfolio and Select Watchlist.

[[internal_footer]]

    This is an online snapshot of a newsletter created by the owner of Small Cap Premium Service (DJ Dunkerley, 86 East 23rd Ave, v5v 1w9 Vancouver, Canada) and sent via GetResponse on 2021-02-12. Report abuse